| scholarly article | Q13442814 |
| P2093 | author name string | Li Li | |
| Qi Wang | |||
| Jia Chen | |||
| Wei Zhang | |||
| Fu-Qiang Yin | |||
| Lin-Hai Yan | |||
| P2860 | cites work | Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China | Q23923302 |
| Maintenance chemotherapy for ovarian cancer | Q24201758 | ||
| Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria | Q24317481 | ||
| Cre-lox-regulated conditional RNA interference from transgenes | Q24564248 | ||
| AKT/PKB signaling: navigating downstream | Q24657857 | ||
| EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells | Q24672969 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida | Q28141956 | ||
| Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase | Q28213355 | ||
| The epigenomics of cancer | Q28289975 | ||
| Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane | Q28647586 | ||
| Targeting multidrug resistance in cancer | Q29616803 | ||
| Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8 | Q29620200 | ||
| Inherited determinants of ovarian cancer survival | Q33638923 | ||
| Relationship between dietary and supplemental intake of folate, methionine, vitamin B6 and folate receptor alpha expression in ovarian tumors | Q33765535 | ||
| A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer | Q34091420 | ||
| Long-term cisplatin exposure impairs autophagy and causes cisplatin resistance in human lung cancer cells | Q34141265 | ||
| Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies | Q34768789 | ||
| Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway. | Q34866669 | ||
| CpG-island methylation and epigenetic control of resistance to chemotherapy. | Q35928398 | ||
| Folate intake and methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers for ovarian cancer risk | Q35933841 | ||
| Role of mitochondria as the gardens of cell death | Q36263117 | ||
| Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia | Q37096589 | ||
| Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma | Q37428076 | ||
| Genetic variation in the one-carbon transfer pathway and ovarian cancer risk | Q37450640 | ||
| Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance | Q37478653 | ||
| Autophagy and ionizing radiation in tumors: the "survive or not survive" dilemma | Q38010124 | ||
| Autophagy suppresses melanoma tumorigenesis by inducing senescence | Q39050017 | ||
| Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo | Q39671100 | ||
| Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis | Q39901280 | ||
| Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance. | Q40169144 | ||
| Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells | Q40272840 | ||
| 5-aza-2'-deoxycytidine upregulates caspase-9 expression cooperating with p53-induced apoptosis in human lung cancer cells | Q40531794 | ||
| Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics | Q41933492 | ||
| One-carbon metabolism-related gene polymorphisms and risk of breast cancer | Q44933198 | ||
| Establishment of 5 resistant ovarian cancer cell strains and expression of resistance-related genes | Q45019004 | ||
| Alcohol drinking and one-carbon metabolism-related gene polymorphisms on pancreatic cancer risk | Q46325252 | ||
| Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis | Q46491223 | ||
| Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma | Q46593237 | ||
| Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer | Q50447436 | ||
| Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies. | Q53287202 | ||
| One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study. | Q53544221 | ||
| Folate metabolic gene polymorphisms and childhood acute lymphoblastic leukemia: a case-control study. | Q53585636 | ||
| Methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers in ovarian cancer risk. | Q54313546 | ||
| Methionine Synthase Reductase Gene A66G Polymorphism is Associated with Risk of Colorectal Cancer | Q55036516 | ||
| Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case–control study | Q57918718 | ||
| Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE) | Q58317417 | ||
| A66G and C524T polymorphisms of the methionine synthase reductase gene are associated with congenital heart defects in the Chinese Han population | Q82372468 | ||
| Interactions of 5'-UTR Thymidylate Synthase Polymorphism with 677C→ T Methylene Tetrahydrofolate Reductase and 66A→ G Methyltetrahydrofolate Homocysteine Methyl-transferase Reductase Polymorphisms Determine Susceptibility to Coronary Artery Disease | Q85230620 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autophagy | Q288322 |
| cisplatin | Q412415 | ||
| ovarian carcinoma | Q18556145 | ||
| P304 | page(s) | 1510-1527 | |
| P577 | publication date | 2015-09-15 | |
| P1433 | published in | American Journal of Translational Research | Q4744272 |
| P1476 | title | MTRR silencing inhibits growth and cisplatin resistance of ovarian carcinoma via inducing apoptosis and reducing autophagy | |
| P478 | volume | 7 |
| Q64098517 | Aberrant Expression of Folate Metabolism Enzymes and Its Diagnosis and Survival Prediction in Ovarian Carcinoma |
| Q37696331 | Autophagy as an emerging therapy target for ovarian carcinoma |
| Q38795910 | Autophagy regulates resistance of non-small cell lung cancer cells to paclitaxel |
| Q99604766 | B Vitamins and One-Carbon Metabolism: Implications in Human Health and Disease |
| Q36841375 | Colorectal cancer cells are resistant to anti-EGFR monoclonal antibody through adapted autophagy |
| Q92890176 | Deregulation of folate pathway gene expression correlates with poor prognosis in acute leukemia |
| Q64233753 | Differential effects of ginkgol C17:1 on cisplatin-induced cytotoxicity: Protecting human normal L02 hepatocytes versus sensitizing human hepatoma HepG2 cells |
| Q49335119 | Effects of ginkgol C17:1 on cisplatin-induced autophagy and apoptosis in HepG2 cells |
| Q39200379 | Insulin-like growth factor 1 antagonizes lumbar disc degeneration through enhanced autophagy |
| Q42293431 | Redox-Related Epigenetic Mechanisms in Glioblastoma: Nuclear Factor (Erythroid-Derived 2)-Like 2, Cobalamin, and Dopamine Receptor Subtype 4 |
| Q47096017 | Role of HIF-1a in regulating autophagic cell survival during cerebral ischemia reperfusion in rats |
| Q37732938 | Tetrahydrocurcumin reduces oxidative stress-induced apoptosis via the mitochondrial apoptotic pathway by modulating autophagy in rats after traumatic brain injury |
Search more.